Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro
about
Cell-Penetrating Peptide as a Means of Directing the Differentiation of Induced-Pluripotent Stem CellsMyogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement TherapyEarly pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells.From pluripotency to myogenesis: a multistep process in the dishDifferentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophyA novel strategy for enrichment and isolation of osteoprogenitor cells from induced pluripotent stem cells based on surface marker combinationA Novel Protocol for Directed Differentiation of C9orf72-Associated Human Induced Pluripotent Stem Cells Into Contractile Skeletal Myotubes.Enhanced Development of Skeletal Myotubes from Porcine Induced Pluripotent Stem Cells.Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability.Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes.Myogenic Differentiation from MYOGENIN-Mutated Human iPS Cells by CRISPR/Cas9.Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular Dystrophy.Skeletal muscle generated from induced pluripotent stem cells - induction and application.Expansion and Purification Are Critical for the Therapeutic Application of Pluripotent Stem Cell-Derived Myogenic Progenitors.Derivation of human differential photoreceptor cells from adult human dermal fibroblasts by defined combinations of CRX, RAX, OTX2 and NEUROD.Dual gene expression in embryoid bodies derived from human induced pluripotent stem cells using episomal vectors.Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.Primary Human Uterine Leiomyoma Cell Culture Quality Control: Some Properties of Myometrial Cells Cultured under Serum Deprivation Conditions in the Presence of Ovarian Steroids.piggyBac-ing models and new therapeutic strategies.Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytesSynergizing Engineering and Biology to Treat and Model Skeletal Muscle Injury and Disease.Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.Minireview: Genome Editing of Human Pluripotent Stem Cells for Modeling Metabolic Disease.Precise Correction of Disease Mutations in Induced Pluripotent Stem Cells Derived From Patients With Limb Girdle Muscular DystrophyTransient ectopic expression of the histone demethylase JMJD3 accelerates the differentiation of human pluripotent stem cells.Identification of transcription factors for lineage-specific ESC differentiation.Role of mesenchymal stem cells in cell life and their signaling.Genome Editing Gene Therapy for Duchenne Muscular Dystrophy.iPS cells: a game changer for future medicine.Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes.Generation of skeletal muscle cells from pluripotent stem cells: advances and challengesStem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy.Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro.Induced pluripotent stem cell technology: a decade of progress.HPGCD outperforms HPBCD as a potential treatment for Niemann-Pick disease type C during disease modeling with iPS cells.Epigenetic Manipulation Facilitates the Generation of Skeletal Muscle Cells from Pluripotent Stem Cells.Skeletal Muscle Cell Induction from Pluripotent Stem Cells.Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy.Differentiation of control and ALS mutant human iPSCs into functional skeletal muscle cells, a tool for the study of neuromuscolar diseases.Three-Dimensional Culture Model of Skeletal Muscle Tissue with Atrophy Induced by Dexamethasone.
P2860
Q26777415-0D09F6A8-FCE0-47E5-84A4-BE99409CB103Q26799633-358EDD93-81CE-439D-9815-FC6A5C9F9AE2Q27308743-D16B2CE3-2EB0-4A05-A654-FFE881AA9D94Q28076485-2A499645-DD50-4354-AEAE-A78266D12B50Q28265827-DEE3BF6F-68CE-4617-A3D2-9838D22A57BEQ28539525-C0FD1D03-C922-4A9A-8DAA-E39FD6D83A29Q30824665-782200AA-2D88-4589-8B57-6B0910B5F0D1Q30837631-7C7B52F8-2844-4EC5-89BA-2115BC37722BQ30838313-31D1F0E9-FA64-4AD3-AC8B-6806C4292EA1Q33559698-4A6F9471-C0D4-4A7C-901B-90F979D088A7Q33573651-841A29A2-31BF-4A67-B554-990DD4AD6597Q33678893-7551C7CD-7EC1-4CF5-B7A0-C1D4A58ECBFBQ33854768-F2D721B7-E633-4BD4-8351-23FF66A174F0Q33905388-7D51E29A-A844-408E-A7BD-2BEC468A1EFCQ34542838-8C4D37D9-B5FB-42E3-AE6E-A1B0ED7744E8Q34652434-5D6C348B-68E9-420B-9733-6306CFA8F68CQ36059427-9B538685-E7CF-45AF-9CB8-23723C09ED77Q36071259-2FC85814-2EE3-4354-A7F7-8D8A0C7A3F1FQ36330999-ACF278D0-5371-4F89-989D-940CF7E6C24CQ36442713-FE953581-D974-459C-8A47-66CBF4C541A1Q36874154-E11F3F61-F79A-419D-840B-7BE93FEA8D8EQ36904682-52C222A2-A98B-4E96-8986-7E2E77F67028Q36945218-08351408-8FA6-4D7D-A246-72F7FBE48BF3Q36951286-FA6DA048-4447-402D-A0B1-FEAD1E093E59Q37381245-B3C0CF61-B043-4264-8BC7-19BD6BA5BA81Q37410916-522AE5C6-809F-46D9-BB20-0554D9852772Q37589437-0FE5D962-5C8C-44B4-B446-52DFCF9C1ED1Q37589752-C4BD495F-A55B-4C61-9998-63957A63DE14Q38185513-E0654DD2-30AF-4838-BBF7-5B7B8881B403Q38321965-DBC9553C-BCE5-4385-93F6-E935AE82DE78Q38510396-5173C1D8-B071-417E-A4BA-5F416948109DQ38577279-3F610698-B840-4A08-933C-2A07587EB448Q38748704-1E5CB285-39D6-41DC-A81C-8ED7495ECDA6Q39040578-CC9E4724-FFB8-467C-B449-FED2B66CC7B3Q39072413-F91E8506-89A5-49D9-8F9B-9B2BC88E9673Q39296894-D9A12FED-D5D5-4C2B-8627-3C0EB264A1C5Q39321274-4B37B8CA-8FC7-4092-9D28-EB5942E4B372Q39368114-D5E531B7-306D-4191-9C10-F8AF9B8868E2Q41002189-746639AC-B6EB-4F0B-B878-4C9F166985BDQ41512207-AD36D741-F0CC-45BA-BDA0-B59B127115A5
P2860
Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Efficient and reproducible myo ...... ling Miyoshi Myopathy in vitro
@ast
Efficient and reproducible myo ...... ling Miyoshi Myopathy in vitro
@en
Efficient and reproducible myo ...... ling Miyoshi Myopathy in vitro
@nl
type
label
Efficient and reproducible myo ...... ling Miyoshi Myopathy in vitro
@ast
Efficient and reproducible myo ...... ling Miyoshi Myopathy in vitro
@en
Efficient and reproducible myo ...... ling Miyoshi Myopathy in vitro
@nl
prefLabel
Efficient and reproducible myo ...... ling Miyoshi Myopathy in vitro
@ast
Efficient and reproducible myo ...... ling Miyoshi Myopathy in vitro
@en
Efficient and reproducible myo ...... ling Miyoshi Myopathy in vitro
@nl
P2093
P2860
P50
P3181
P1433
P1476
Efficient and reproducible myo ...... ling Miyoshi Myopathy in vitro
@en
P2093
Akihito Tanaka
Atsuko Sehara-Fujisawa
Hidetoshi Sakurai
Katsuya Miyake
Kazunori Hanaoka
Ken-Ichi Isobe
Nobuharu Fujii
Takumi Era
Takuya Yamamoto
Tokiko Nishino
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0061540
P407
P577
2013-01-01T00:00:00Z